HS-25

DRUG2 trials

Sponsors

Zhejiang Hisun Pharmaceutical Co. Ltd.

Conditions

Primary Hypercholesterolemia

Phase 2

A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia

CompletedNCT02087917

Zhejiang Hisun Pharmaceutical Co. Ltd.Primary Hypercholesterolemia

Start: 2014-03-31End: 2014-12-31Updated: 2015-01-06

Phase 3

Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia

CompletedNCT03413462

Zhejiang Hisun Pharmaceutical Co. Ltd.Primary Hypercholesterolemia

Start: 2016-04-12End: 2018-09-20Updated: 2018-10-18